Categories:

Rob MacCuspie, Regulatory Manager at Proxima Clinical Research, is here to discuss the similarities and differences between two major FDA submission programs: Breakthrough Device Designation (BDD) and the Safer Technologies Program (STeP)! The programs are closely related, so it's important to understand the nuances of both in order to best choose the path that's best for you and your product! Watch to learn more.

More Questions? We're here to help!
SPEAK WITH A SPECIALIST